A XM não fornece serviços a residentes nos Estados Unidos da América.

Dow rally drives Wall St higher as rate-cut hopes stay strong



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Dow rally drives Wall St higher as rate-cut hopes stay strong</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

June retail sales stronger than expected

BofA profit beats expectation

UnitedHealth rises after Q2 profit beats estimates

Match up on report activist investor Starboard built stake

Indexes up: Dow 0.97%, S&P 0.36%, Nasdaq 0.18%

Updated at 9:56 a.m. ET/ 1356 GMT

By Lisa Pauline Mattackal and Ankika Biswas

July 16 (Reuters) - The Dow led Wall Street's main indexes higher on Tuesday, boosted by UnitedHealth's strong results and as unexpectedly robustretail sales data signaled a still-resilient U.S. economy, but did little to dampen rate-cut bets.

UnitedHealth Group UNH.N jumped 4.3% following a second-quarter profit beat, lifting the blue-chip Dow .DJI and the S&P 500 Health Care index .SPXHC to all-time highs.

Among other corporate earnings, Bank of America BAC.N jumped3.6% after an upbeat netinterest-income forecast and better-than-expected second-quarter profit, steering the S&P 500 Financials index .SPSY to a record high.

Morgan Stanley MS.N fell1% after its wealth management revenue missed estimates, while Charles Schwab SCHW.N slumped7% after posting lowernet income.

A Commerce Department report showed retail sales were unchanged in June, when they were expected to fall 0.3%, while retail sales minus automobiles jumped 0.4%, versus forecasts of a flat reading.

However, traders are fully pricing in a rate reduction by September, with the odds of a 25-basis-point cut standing at 93%, according to the CME's FedWatch tool.

"Investors, at first, were likely disappointed because it might not assist in helping the Fed make a decision about cutting rates. But at the same time, it's offering comfort that the U.S. economy is not headed toward recession anytime soon," said Sam Stovall, chief investment strategist, CFRA Research.

"The momentum trade will likely continue, especially with a broadening into the smaller cap companies within the U.S. investor marketplace."

The small-cap Russell 2000 index .RUT jumped 2% to its highest level since January 2022, as investors continue to move away from heavily weighted tech stocks, which have driven much of Wall Street's rally this year.

Strong betson a rate cut by the U.S. Federal Reserve inSeptember and a second term for presidential candidate Donald Trump followingan assassination attempt had prompted an upbeat start to the week for Wall Street.

However, Trump-linked stocks retreated after Monday's rally, with Trump Media & Technology Group DJT.O and software firm Phunware PHUN.O losing between 3% and 8%.

Markets read itas a dovish signal when Fed Chairman Jerome Powell said on Monday that the latest economic data "add(s) somewhat to confidence" that inflation was returning to the central bank's 2% target.

At 9:56 a.m. ET, the Dow Jones Industrial Average .DJI was up 388.12 points, or 0.97%, at 40,599.84, the S&P 500 .SPX was up 20.10 points, or 0.36%, at 5,651.32, and the Nasdaq Composite .IXIC was up 33.73 points, or 0.18%, at 18,506.29.

Among top megacap movers, Nvidia NVDA.O was down 1.6%, while Amazon.com AMZN.O rose 1%.

The S&P 500 Communication Services index .SPLRCL jumped 1%, led by an8.3% rise in Tinder-owner Match MTCH.O, after a report that activist investor Starboard has a stake of over 6.5% in the company and was pushing for a possible sale if a turnaround wasn't successful.

Advancing issues outnumbered decliners by a 3.67-to-1 ratio on the NYSE, and by a 3.10-to-1 ratio on the Nasdaq.

The S&P index recorded 53 new 52-week highs and three new lows, while the Nasdaq recorded 200 new highs and 16 new lows.



Reporting by Lisa Mattackal in Bengaluru; Editing by Pooja Desai

</body></html>

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.